Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001104659-22-080876
Filing Date
2022-07-19
Accepted
2022-07-20 09:16:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFC14A tm2221387-1_defc14a.htm DEFC14A 1202895
2 GRAPHIC image_001.jpg GRAPHIC 4715
  Complete submission text file 0001104659-22-080876.txt   1210853
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 000-51173 | Film No.: 221092958
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2200 FLETCHER AVENUE SUITE 501 FORT LEE NJ 07024
Business Address
SINGER JULIAN D. (Filed by) CIK: 0001628706 (see all company filings)

Type: DEFC14A